英文名称 | 中文名称 | CAS |
---|---|---|
LY 294002 | LY294002/PI3K抑制剂 | 154447-36-6 |
Tenalisib (RP6530) | RP6530 | 1639417-53-0 |
XL147 analogue | XL147 | 956958-53-5 |
Voxtalisib (SAR245409, XL765) | XL765 | 1349796-36-6 |
AZD8055 | AZD8055 | 1009298-09-2 |
AZD8835 | AZD-8835 | 1620576-64-8 |
OSI-027 | 反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-F][1,2,4]三嗪-7-基]环己烷羧酸 | 936890-98-1 |
PF-4989216 | 4-(4-氰基-2-氟苯基)-2-吗啉-5-(1H-1,2,4-三唑-5-基)噻吩-3-腈 | 1276553-09-3 |
PI-103 | PI-103 | 371935-74-9 |
PIK-III | PIK-III | 1383716-40-2 |
Pilaralisib (XL147) | 2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 | 934526-89-3 |
Sapanisertib (INK 128, MLN0128) | 3-(2-氨基-5-苯并恶唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺 | 1224844-38-5 |
Torin 1 | 1-[4-[4-(1-氧代丙基)-1-哌嗪基]-3-(三氟甲基)苯基]-9-(3-喹啉基)苯并[H]-1,6-萘啶-2(1H)-酮 | 1222998-36-8 |
Torkinib (PP242) | PP242 | 1092351-67-1 |
Vistusertib (AZD2014) | 3-[2,4-双((3S)-3-甲基吗啉-4-基)吡啶并[5,6-E]嘧啶-7-基]-N-甲基苯甲酰胺 | 1009298-59-2 |
VPS34-IN1 | VPS34-IN1 | 1383716-33-3 |
WYE-125132 (WYE-132) | N-[4-[1-(1,4-二氧杂螺[4.5]癸烷-8-基)-4-(8-氧杂-3-氮杂双环[3.2.1]辛烷-3-基)-1H-吡唑并[3,4-D]嘧啶-6-基]苯基]-N'-甲基脲 | 1144068-46-1 |
WYE-354 | 4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-吗啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯 | 1062169-56-5 |
A-674563 | A-674563 | 552325-73-2 |
Akti-1/2 | 1,3-二氢-1-[1-[[4-(6-苯基-1H-咪唑并[4,5-G]喹喔啉-7-基)苯基]甲基]-4-哌啶基]-2H-苯并咪唑-2-酮 | 612847-09-3 |
AT13148 | AT13148 | 1056901-62-2 |
AZD5363 | 4-氨基-N-[(1S)-1-(4-氯苯基)-3-羟基丙基]-1-(7H-吡咯并[2,3-D]嘧啶-4-基)-4-哌啶甲酰胺 | 1143532-39-1 |
CC-223 | CC-223 | 1228013-30-6 |
CHIR-99021 (CT99021) HCl | CHIR-99021盐酸盐 | 1797989-42-4 |
GDC-0349 | N-ETHYL-N'-[4-[5,6,7,8-四氢-4-[(3S)-3-甲基-4-吗啉基]-7-(3-氧杂环丁基)吡啶并[3,4-D]嘧啶-2-基]苯基]脲 | 1207360-89-1 |
GSK690693 | 4-[2-(4-氨基-1,2,5-恶二唑-3-基)-1-乙基-7-[(3S)-3-哌啶基甲氧基]-1H-咪唑并[4,5-C]吡啶-4-基]-2-甲基-3-丁炔-2-醇 | 937174-76-0 |
Ipatasertib (GDC-0068) | 帕他色替 | 1001264-89-6 |
LY2090314 | LY 2090314 | 603288-22-8 |
Palomid 529 (P529) | PALOMID 529 (P529) | 914913-88-5 |
Perifosine (KRX-0401) | 哌立福辛 | 157716-52-4 |
SB216763 | SB216763 | 280744-09-4 |
SC79 | 2-氨基-6-氯-ALPHA-氰基-3-(乙氧羰基)-4H-1-苯并吡喃-4-乙酸乙酯 | 305834-79-1 |
TIC10 Analogue | TIC-10 | 41276-02-2 |
Triciribine | 曲西瑞宾 | 35943-35-2 |
Uprosertib (GSK2141795) | UPROSERTIB | 1047634-65-0 |
4SC-202 | 4SC-202(盐的形式) | 1186222-89-8 |
Abexinostat (PCI-24781) | PCI-24781 | 783355-60-2 |
ACY-738 | N-羟基-2-[(1-苯基环丙基)氨基]-5-嘧啶甲酰胺 | 1375465-91-0 |
AR-42 | AR-42 | 935881-37-1 |
AZ32 | 1353002-02-4 | |
AZD2461 | 4-[4-氟-3-[(4-甲氧基哌啶-1-基)羰基]苄基]酞嗪-1(2H)-酮 | 1174043-16-3 |
AZD6738 | AZD6738 | 1352226-88-0 |
CUDC-101 | 7-[[4-(3-乙炔基苯基氨基)-7-甲氧基喹唑啉-6-基]氧基]-N-羟基庚酰胺 | 1012054-59-9 |
G007-LK | G007-LK | 1380672-07-0 |
Givinostat (ITF2357) | [4-[(羟基氨基)羰基]苯基]氨基甲酸 [6-[(二乙基氨基)甲基]-2-萘基]甲酯 | 497833-27-9 |
LY2584702 Tosylate | LY2584702 TOSYLATE | 1082949-68-5 |
Mocetinostat (MGCD0103) | N-(2-氨基苯基)-4-([[4-(吡啶-3-基)嘧啶-2-基]氨基]甲基)苯甲酰胺 | 726169-73-9 |
NVP-TNKS656 | NVP-TNKS656 | 1419949-20-4 |
Pracinostat (SB939) | (2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羟基丙烯酰胺 | 929016-96-6 |
Quisinostat (JNJ-26481585) | JNJ 26854165 | 875320-29-9 |
Ricolinostat (ACY-1215) | ACY1215 | 1316214-52-4 |
Tasquinimod | 他喹莫德 | 254964-60-8 |
TMP269 | TMP269 | 1314890-29-3 |
VE-821 | 3-氨基-6-[4-(甲基磺酰基)苯基]-N-苯基-2-吡嗪甲酰胺 | 1232410-49-9 |
AT9283 | AT9283 | 896466-04-9 |
AZ 960 | 5-氟-2-[[(1S)-1-(4-氟苯基)乙基]氨基]-6-[(5-甲基-1H-吡唑-3-基)氨基]-3-吡啶腈 | 905586-69-8 |
BAY 87-2243 | BAY87-2243 | 1227158-85-1 |
BMS-911543 | BMS-911543 | 1271022-90-2 |
CEP-33779 | N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺酰基)苯基]-[1,2,4]三唑并[1,5-A]吡啶-2-胺 | 1346168-57-7 |
Danusertib (PHA-739358) | 达鲁舍替 | 827318-97-8 |
Daprodustat (GSK1278863) | 达普司他 | 960539-70-2 |
Decernotinib (VX-509) | 迪西替尼 | 944842-54-0 |
FG-2216 | BIQ | 223387-75-5 |
Filgotinib (GLPG0634) | 非戈替尼 | 1206161-97-8 |
FM-381 | (E)-2-CYANO-3-(5-(1-CYCLOHEXYL-1,6-DIHYDROIMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-2-YL)FURAN-2-YL)-N,N-DIMETHYLACRYLAMIDE | 2226521-65-7 |
Gandotinib (LY2784544) | LY 2784544 | 1229236-86-5 |
GLPG0634 analogue | GLPG0634 | 1206101-20-3 |
Itacitinib (INCB39110) | 伊他替尼 | 1334298-90-6 |
Momelotinib (CYT387) | 莫洛替尼 | 1056634-68-4 |
NVP-BSK805 | NVP-BSK805 dihydrochloride | 1092499-93-8 |
PIM447 | LGH447 | 1210608-43-7 |
SNS-314 Mesylate | N-(3-氯苯基)-N'-[5-[2-(噻吩并3,2-D]嘧啶-4-基氨基)乙基]-2-噻唑基]脲甲磺酸盐 (1:1) | 1146618-41-8 |
S-Ruxolitinib (INCB018424) | S-鲁索替尼 | 941685-37-6 |
XL019 | XL019 | 945755-56-6 |
(R)-(-)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate | (R)-(-)2-(4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮杂环庚烷-6-基)乙酸叔丁酯 | 1268524-71-5 |
ABBV-744 | ABBV-744 | 2138861-99-9 |
AGK2 | 2-氰基-3-[5-(2,5-二氯苯基)-2-呋喃基]-N-5-喹啉基-2-丙烯酰胺 | 304896-28-4 |
AMG-900 | AMG 900 | 945595-80-2 |
BI-7273 | CS-2327 | 1883429-21-7 |
BI-847325 | BI-847325 | 1207293-36-4 |
ENMD-2076 | 6-(4-甲基-1-哌嗪基)-N-(5-甲基-1H-吡唑-3-基)-2-[(1E)-2-苯乙烯基]-4-嘧啶胺 | 934353-76-1 |
GSK1070916 | GSK1070916 | 942918-07-2 |
JNJ-7706621 | Jnj-7706621 | |
MK-5108 (VX-689) | MK-5108 (VX-689) | 1010085-13-8 |
MS436 | (E)-4-((2-AMINO-4-HYDROXY-5-METHYLPHENYL)DIAZENYL)-N-(PYRIDIN-2-YL)BENZENESULFONAMIDE | 1395084-25-9 |
OSS_128167 | OSS-128167 | 887686-02-4 |
PHA-680632 | PHA-680632 | 398493-79-3 |
SGC-CBP30 | SGC-CBP30 | 1613695-14-9 |
SNS-314 | N-(3-氯苯基)-N'-[5-[2-(噻吩并[3,2-D]嘧啶-4-基氨基)乙基]-2-噻唑基]脲 | 1057249-41-8 |
SRT1720 HCl | SRT1720 | 1001645-58-4 |
SRT2104 (GSK2245840) | 玻玛西林 | 1093403-33-8 |
TAK-901 | 5-[3-(乙基磺酰基)苯基]-3,8-二甲基-N-(1-甲基-4-哌啶基)-9H-吡啶并[2,3-B]吲哚-7-甲酰胺 | 934541-31-8 |
Tenovin-6 | TENOVIN-6 | 1011557-82-6 |
AT9283 | AT9283 | 896466-76-5 |
AZD1480 | 5-氯-N2-[(1S)-1-(5-氟-2-嘧啶基)乙基]-N4-(5-甲基-1H-吡唑-3-基)-2,4-嘧啶二胺 | 935666-88-9 |
AZD5153 | AZD5153结晶体(API形式) | 1869912-40-2 |
EED226 | EED226 | 2083627-02-3 |
EPZ004777 | EPZ004777 | 1338466-77-5 |
EPZ005687 | EPZ005687 | 1396772-26-1 |
EPZ015666 | EPZ015666 | 1616391-65-1 |
联系方式
电话:021-50822001
邮箱:marketing@medicilon.com.cn
网址: http://www.medicilon.com.cn
产品总数: 1152
地址:川大路585号
CB指数:58
国籍:中国